Abstract

Church & Dwight will report fiscal first-quarter 2026 results on May 1, 2026 Pre-Market, with current expectations pointing to revenue of 1.46 billion US dollars (down 3.78% year over year) and adjusted EPS near 0.93, as investors gauge pricing, mix, and input-cost dynamics against portfolio changes and brand investment.

Market Forecast

Consensus for the upcoming quarter centers on revenue of 1.46 billion US dollars, a 3.78% year-over-year decline, adjusted EPS around 0.93 implying 3.71% growth year over year, and EBIT of 297.65 million US dollars down 1.80% year over year. Company-level margin guidance for the quarter is not specified, though forecasts imply modest EPS growth despite the revenue decline tied to portfolio pruning.

The main business remains consumer net sales, which anchored last quarter’s top line and is expected to continue leading performance through pricing, mix, and distribution; within that, portfolio investment in select brands is a key 2026 theme. The most promising area is personal care within the consumer portfolio, supported by stepped-up brand support and innovation; last quarter, consumer net sales contributed 1.57 billion US dollars as overall company revenue rose 3.93% year over year.

Last Quarter Review

In the prior quarter (fiscal fourth-quarter 2025), Church & Dwight delivered 1.64 billion US dollars of revenue, a gross profit margin of 45.52%, GAAP net profit attributable to shareholders of 144.00 million US dollars, a net profit margin of 8.73%, and adjusted EPS of 0.86, with revenue up 3.93% year over year and adjusted EPS up 11.69% year over year. A key financial highlight was EBIT growth of 9.60% year over year to 282.10 million US dollars, while net profit stepped down quarter on quarter by 21.24%, reflecting seasonal effects and reinvestment. By business, consumer net sales accounted for 1.57 billion US dollars and specialty products for 73.20 million US dollars; the company’s top line advanced 3.93% year over year, with consumer-led strength offsetting smaller contributions elsewhere.

Current Quarter Outlook

Main business: consumer net sales

Consumer net sales is set to remain the core driver this quarter. Forecasts point to revenue of 1.46 billion US dollars, down 3.78% year over year, which aligns with an anticipated temporary drag from portfolio pruning and divestitures. Despite the top-line decline, EPS growth of 3.71% and an EBIT decline of 1.80% suggest an underlying margin narrative that balances productivity and mix against reinvestment and input inflation. The cadence of promotions in everyday essentials and personal care, combined with distribution gains on priority brands, should help sustain volume where price carryover from 2025 normalizes. Channel execution and merchandising resets at key retailers will be important for baseline velocities as price elasticity remains in check for core consumables.

The translation of pricing into margins depends on realized mix and procurement benefits. Recent commentary around 2026 points to productivity and portfolio optimization as supports for gross margin progression, which, if visible in Q1, would underpin EPS resilience despite the revenue headwind. In practical terms, that means the company will lean on manufacturing efficiencies, SKU rationalization, and a higher share of premiumized propositions to offset higher selling and marketing in the first half tied to brand launches. On balance, the consumer franchise should show healthy fundamentals even if reported revenue is lower year over year due to portfolio actions rather than core demand.

Operationally, shipment timing and retailer inventory movements can create noise versus consumption. The fourth quarter showed a 45.52% gross margin, providing a base that may be improved incrementally if productivity and mix tailwinds absorb commodity and logistics costs. Monitoring the balance between advertising growth and margin expansion is crucial: management’s willingness to reinvest behind brands can pressure operating margins short term, but it is typically supportive of sustained share and pricing power.

Most promising business: personal care brand engines within Consumer

Within the consumer portfolio, personal care remains a relative bright spot for 2026, supported by stepped-up investment and innovation. External previews point to heavier spending in the first half to scale recently acquired or expanded platforms, with ongoing distribution wins and product extensions expected to support consumption. This quarter, that higher spending may weigh on near-term EBIT, yet it is expected to build a stronger run-rate into the back half as brand awareness and shelf productivity improve.

While the company does not disclose brand-level revenue in the tool dataset, the structure of last quarter’s revenue—1.57 billion US dollars from consumer net sales and 73.20 million US dollars from specialty products—shows where scale resides. As a result, incremental growth from personal care innovation has an outsized impact on total-company momentum. For the quarter, investors will look for evidence that trade activation, digital media, and in-store execution translate into velocities that offset any fading price carryover. If the personal care pipeline delivers, it can aid mix and margin, especially where premium offerings command stronger unit economics.

Portfolio moves also play a role. The exit from slower-growing businesses reweights the company toward higher-return platforms in personal care and home care. That can compress near-term reported revenue, but it sharpens the growth profile in categories with stronger household penetration runways and higher marketing ROI. The net of these actions should be visible in the quality of sales—more repeat purchase, better price/mix, and improved gross margin—rather than sheer volume. Success will be measured by sustained consumption growth outpacing reported sales if divestitures mask underlying demand.

Key stock price drivers this quarter

The first driver is the earnings bridge—how gross margin, operating expenses, and EBIT reconcile to the EPS print versus expectations around 0.93. A small revenue miss can be neutralized by gross margin uplift from productivity and mix, whereas a shortfall in margin could dominate the narrative even if revenue meets the 1.46 billion US dollars mark. Conversely, an in-line or better gross margin combined with disciplined expense control could set a constructive tone for the year despite the anticipated year-over-year revenue decline.

The second driver is management’s qualitative and quantitative framing of full-year 2026. External commentary points to organic sales growth of roughly 3% to 4% for the year and approximately 100 basis points of gross margin expansion in 2026, with heavier first-half spending to support personal care. If those elements are reaffirmed while Q1 tracks the EPS trajectory implied by estimates, the market may look through the short-term revenue dip. Guidance color on second-half normalization, productivity savings, and advertising cadence will be key signposts.

The third driver is cost inflation, especially oil-linked packaging resins. Recent broker work across the household and personal care complex has highlighted a potential uptick in resin costs that could challenge margin recapture if sustained. If Church & Dwight updates on procurement, hedging, and price realization to counter resin and logistics, investors can better gauge the durability of gross margin expansion. The balance of commodity headwinds versus internal productivity and portfolio mix will likely shape the stock’s reaction more than top-line fluctuations.

Analyst Opinions

Across published opinions from January 1, 2026 through April 24, 2026, the ratio of bullish to bearish views is tilted in favor of the bulls, with more Buy/Outperform/Overweight stances than Sell ratings. Among the bullish cohort, Oppenheimer reaffirmed an Outperform stance and lifted its price target to 115 US dollars, citing brand momentum and a favorable 2026 earnings algorithm that includes gross margin expansion and steady organic growth. Goldman Sachs maintained a Buy rating with a 109 US dollar target, emphasizing the company’s execution on portfolio optimization and productivity as supports for margin and EPS resilience in the face of transitional revenue headwinds.

Wells Fargo reiterated an Overweight rating and raised its target to 110 US dollars, focusing on the visibility of reinvestment translating into consumption gains for priority brands. Argus increased its target to 112 US dollars while maintaining a Buy rating, pointing to balanced drivers across pricing, mix, and productivity that underpin mid-single-digit adjusted EPS growth for the year. RBC remained in the bullish camp with an Outperform rating and a 112 US dollar target, noting portfolio changes that sharpen the growth profile and an expected first-quarter adjusted EPS around 0.92, consistent with a setup where reported revenue is temporarily weighed by divestitures but underlying profitability is supported by gross margin improvements.

On net, bullish opinions outnumber bearish ones by a wide margin during the period, so the prevailing view is constructive heading into the print. The positive stance rests on three pillars. First, brand investment should accelerate personal care momentum and support share while pricing normalizes. Second, productivity and mix are expected to lift gross margin by about a percentage point over 2026, giving the company room to fund advertising and still deliver EPS growth even if revenue is temporarily lower due to portfolio actions. Third, estimates for the quarter—revenue of about 1.46 billion US dollars, adjusted EPS near 0.93, and EBIT around 297.65 million US dollars—appear achievable given the balance of reinvestment and cost discipline implied by recent communications. If management corroborates these trends and provides confident full-year framing, the majority of analysts expect a constructive reception, with upside skew driven more by margin quality and guidance cadence than by headline revenue.